Bleichroeder Acquisition Corp. II | News Search

跳至主要内容

MedPath Trial Home

机构资讯 AI 研究

数据来源：ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

搜索试验。追踪管线。洞察审批。由 AI 驱动的临床研究情报平台。

产品

临床试验
药物情报
全球审批
深度研究
价格方案

资源

常见问题
搜索

公司

资讯
关于我们
联系我们

法律

隐私政策
服务条款

免责声明： 本网站提供信息检索和数据分析服务。内容不构成医疗建议。适应性评估仅供参考，不能替代合格医疗专业人员的咨询。数据来源于公共注册库和监管机构；MedPath 不保证数据的完整性或准确性。请以原始资料为准。

© 2026 MedPath Trial 版权所有

服务条款隐私政策

我们重视您的隐私

我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。

找到 46,618 条关于 “Bleichroeder Acquisition Corp. II”

Bleichroeder Acquisition Corp. II Completes $287.5M IPO Targeting Healthcare Technology Disruption

SL Bio and Horizon Space Acquisition II Corp. Announce Merger to Advance Cancer Immunotherapy and Regenerative Medicine

Crown Reserve Acquisition Corp. I and Carvix Announce $1.0 Billion Business Combination Agreement

BriaCell Therapeutics Reports Progress in Phase 3 Metastatic Breast Cancer Trial

BriaCell's Bria-IMT™ Shows Promise in Metastatic Breast Cancer Phase 2 Trial

AbbVie's Emraclidine Fails in Phase II Schizophrenia Trials, Clouding Cerevel Acquisition Value

Scholar Rock's Apitegromab Shows Promise in SMA, Faces Financial and Development Hurdles

Anavex Life Sciences Reports Financial Results and Clinical Advancements in Neurodegenerative Disease Research

Red Light Holland Rebrands to Rhelion Life Sciences, Advances Naturally Derived Psilocybin Drug PEX010 Toward Phase II Clinical Development

AlphaGen Intelligence Corp Announces $195,000 Private Placement for Working Capital

第 1 页，共 625 页